Hylambatin
[Lys6]-Eledoisin (6-11)
Ranatachykinin C
Ranatachykinin B
Histone H4 (1-7); N-Terminal
AMARA peptide
Catestatin; human
Valorphin
LVV-Hemorphin-
MOG (101-120); human; mouse
Pevpyrokinin-
Pevpyrokinin-
Myomodulin
Leucokinin 3
Secretogranin I Precursor (585-594)
Pituitary Adenylate Cyclase-Activating Polypeptide Precursor (111-128)
Gonadoliberin I (24-33)
Delta-Sleep-
CART Protein Precursor (82-86)
alpha-Neo-Endorphin
Ecdysis-Triggering Hormone 1 (ETH1); Drosophila
Preptin; Human Pro-Insulin Growth Factor II (69-80); mouse
MOG (92–106)
P2 p57–81; Peripheral Myelin P2 Protein p57–81
MBP (79-87)
NY-ESO-1 (87-111)
BDC2.5 mimotope 1040-51
BDC2.5 mimotope 1040-31
MMK-1; amide
Dyrktide; TAMRA labeled
Autoimmune Lupus Erythematosus Epitope 1
Heparin-Binding Peptide V; scrambled
Orphanin FQ2; (OFQ2; NOCII)
BQ123; Cyclo(-wdPvL-);
Deltorphin B
Deltorphin C
Dynorphin B (1-9)
Dynorphin B (1-13)
Dermorphin
Lipid Membrane Translocating Peptide; D-isomer
Survivin 2B (80–88)
Tyrosinase (240-251)
MAGE-A 1(96–104)
Metalnikowin IIA
Drosocin
HspB8 (184-196); human
[Pro31]-Beta-
[Val33]-Beta-
[Asn 6;13;14] -Beta-Amyloid (1-42)
Acrylodan
gp100 (25–33); human
Company Info
AnaSpec, Inc. is a leading provider of integrated proteomics solutions to pharmaceutical, biotech, and academic research institutions throughout the world. Established in 1993, AnaSpec's headquarters and manufacturing facilities are located in San Jose, CA.
For more information visit www.anaspec.com





